Robert Ticktin
General Counsel & Chief Operating OfficeratPMV Pharmaceuticals· In the 2025 proxy
Pay in FY2025PMV Pharmaceuticals stock -17.2% the same year
Robert Ticktin was paid $861.2K in FY2025 (Dec). PMV Pharmaceuticals stock fell 17.2% that year.
Pay$100 in the stock at the end of FY24 → $83
Experience
- PMV PharmaceuticalsPublic company · 1 yr
- General Counsel & Chief Operating Officer2025 – Present · 1 yrStock in role -6%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?